Skip header and navigation

4 records – page 1 of 1.

World Medical Association annual meeting

https://policybase.cma.ca/en/permalink/policy1612
Date
2003-Oct-04
Topics
Ethics and medical professionalism
Resolution
BD04-02-19
The Canadian Medical Association will continue its support for and participation in the work of the World Medical Association.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Oct-04
Topics
Ethics and medical professionalism
Resolution
BD04-02-19
The Canadian Medical Association will continue its support for and participation in the work of the World Medical Association.
Less detail

Embryonic stem cell research

https://policybase.cma.ca/en/permalink/policy1619
Date
2003-Dec-06
Topics
Ethics and medical professionalism
Resolution
BD04-04-62
The Canadian Medical Association remains neutral on the issue of embryonic stem cell research.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Dec-06
Topics
Ethics and medical professionalism
Resolution
BD04-04-62
The Canadian Medical Association remains neutral on the issue of embryonic stem cell research.
Less detail

Adverse reactions between alcohol and drug products

https://policybase.cma.ca/en/permalink/policy805
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Less detail

Drug product substitution

https://policybase.cma.ca/en/permalink/policy806
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Less detail